faculty photo

Emily Baumrin, MD, MSCE

Assistant Professor of Dermatology at the Hospital of the University of Pennsylvania
Department: Dermatology

Contact information
3400 Civic Center Boulevard
Perelman Center for Advanced Medicine, South Tower, Suite 729
Philadelphia, PA 19104
Office: (215)-614-0700
Education:
BA (Biochemistry)
Dartmouth College, 2010.
MD (Medicine)
University of Pennsylvania, Perelman School of Medicine, 2015.
MSCE (Epidemiology)
University of Pennsylvania, 2023.
Permanent link
 
> Perelman School of Medicine   > Faculty   > Details

Selected Publications

Baumrin E, Pidala J, Mitchell S, Onstad L, Lee S: Development of the Lee Symptom Scale-Skin Sclerosis for chronic GVHD-associated sclerosis. Blood 145(12): 1321-332, Mar 2025.

Baumrin E, Cronholm P, Kearney M, Mengesha M, Cesar L, Keddem S, Schapira M, Lee S, Loren A, Gelfand J: Outcomes of Importance to Patients Living With Cutaneous Chronic Graft-vs-Host Disease. JAMA Dermatol 161(3): 281-90, Mar 2025.

Alvarado S, Cohen O, Lattanzio K, Haun P, Gelfand J, Loren A, Chung J, Baumrin E: Histopathologic Analysis of Chronic Cutaneous Graft-Versus-Host Disease. Am J Dermatopathol 46(11): 755-60, Nov 2024.

Pidala J, Onstad L, Baumrin E, Carpenter P, Cutler C, Arai S, Kitko C, Chen G, Lee S: Comparison of treatment response measures in cutaneous sclerosis after allogeneic hematopoietic cell transplantation. Blood Adv 8(17): 4651-657, Sep 2024.

Choe J, Shields A, Ferreira A, Gold S, Gotschall J, Kamal K, Rios A, Wang R, Baumrin E, Dommasch E, Yeung H, Lipoff J, Barbieri J: Isotretinoin for Acne in Transgender and Gender-Diverse Individuals Receiving Masculinizing Hormone Therapy. JAMA Dermatol 160(7): 741-45, Jul 2024.

Baumrin E, Shin D, Mitra N, Pidala J, Jurdi N, Lee S, Loren A, Gelfand J: Patient-Reported Outcomes and Mortality in Cutaneous Chronic Graft-vs-Host Disease. JAMA Dermatol 160(4): 393-401, Apr 2024.

Rastogi S, Kim E, Gelfand J, Loren A, Baumrin E: Chronic Graft-versus-Host Disease-Associated Muscle Cramps: Severity and Response to Immunomodulatory Therapies. Transplant Cell Ther 30(3): 338, Mar 2024.

Mital R, Otto T, Savu A, Baumrin E, Cardones A, Carlesimo M, Caro G, Freites-Martinez A, Hirner J, Markova A, McLellan B, Rossi A, Sauder M, Seminario-Vidal L, Sibaud V, Owen D, Dulmage B, Chen S, Kaffenberger B: Detection of novel therapies using a multi-national, multi-institutional registry of cutaneous immune-related adverse events and management. Int J Dermatol 62(8): 1020-25, Aug 2023.

Baumrin E, Baker L, Byrne M, Martin P, Flowers M, Onstad L, Jurdi N, Chen H, Beeghly-Fadiel A, Lee S, Tkaczyk E: Prognostic Value of Cutaneous Disease Severity Estimates on Survival Outcomes in Patients With Chronic Graft-vs-Host Disease. JAMA Dermatol 159(4): 393-402, Apr 2023.

Willer Q, Bowers J, Baumrin E, Lipoff J: Establishment of a dermatology clinic serving both patients living with HIV/AIDS and transgender individuals (PRIDE clinic) in an urban academic setting: Demographics, evolution, and lessons learned. J Am Acad Dermatol 88(4): 882-85, Apr 2023.

back to top
Last updated: 07/24/2025
The Trustees of the University of Pennsylvania